Literature DB >> 5921331

Deferoxamine and diethylenetriaminepentaacetic acid (DTPA) in thalassemia.

R McDonald.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1966        PMID： 5921331     DOI： 10.1016/s0022-3476(66)80041-0

Source DB:  PubMed          Journal:  J Pediatr        ISSN： 0022-3476            Impact factor:   4.406


× No keyword cloud information.
  5 in total

1.  Long-term administration of desferrioxamine in thalassaemia major.

Authors:  R Seshadri; J H Colebatch; P Gordon; H Ekert
Journal:  Arch Dis Child       Date:  1974-08       Impact factor: 3.791

2.  Urinary iron excretion in thalassaemia after desferrioxamine administration.

Authors:  R Seshadri; J H Colebatch; R Fisher
Journal:  Arch Dis Child       Date:  1974-03       Impact factor: 3.791

3.  Desferrioxamine in thalassaemia.

Authors:  M Diwany; M Gabr; A el Hefni; N Mokhtar
Journal:  Arch Dis Child       Date:  1968-06       Impact factor: 3.791

4.  Siderosis, haemolysis or hepatonecrosis in increasing post-desferrioxamine sideruria in acute viral hepatitis?

Authors:  L A Scuro; G Dobrilla
Journal:  Postgrad Med J       Date:  1967-11       Impact factor: 2.401

5.  Innovation for rare diseases and bioethical concerns: A thin thread between medical progress and suffering.

Authors:  Alberto Tommasini; Andrea Magnolato; Irene Bruno
Journal:  World J Clin Pediatr       Date:  2018-08-30
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.